Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2021.708184 http://scihub22266oqcxt.onion/10.3389/fimmu.2021.708184 34354712!8330131!34354712     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Immunol 2021 ; 12 (ä): 708184 Nephropedia Template TP {{tp|p=34354712|t=2021. Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study |pdf=|usr=}}{{34354712}} gab.com Text Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34354712 #FOAvip There is a worldwide pandemic of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; yet our understanding remains limited on the characteristic of antibodies, especially for dynamic long-term tracking. Sequential serum samples were collected up to 416 days post onset of symptoms (POS) from 102 patients who were hospitalized with coronavirus disease 2019 (COVID-19). Immunoglobulin (Ig)G, IgM, and IgA levels targeting SARS-CoV-2 spike 1 receptor-binding domain (S1-RBD), spike 2 extracellular domain (S2-ECD), and nucleocapsid protein (N) were quantified as well as neutralizing activity. We were pleasantly surprised to find that the antibody remained detective and effective for more than a year POS. We also found the varied reactions of different antibodies as time passed: N-IgA rose most rapidly in the early stage of infection, while S2-IgG was present at a high level in the long time of observation. This study described the long traceable antibody response of the COVID-19 and offered hints about targets to screen for postinfectious immunity and for vaccination development of SARS-CoV-2. Twit Text FOAVip Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34354712 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34354712 #FOAvip English Wikipedia <ref>{{Cite pmid|34354712}}</ref> Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study #MMPMID34354712 Shi D; Weng T; Wu J; Dai C; Luo R; Chen K; Zhu M; Lu X; Cheng L; Chen Q; Liu F; Wu Z; Wu H; Jin C; Guo M; Chen Z; Wu N; Yao H; Zheng M Front Immunol 2021[]; 12 (ä): 708184 PMID34354712show ga There is a worldwide pandemic of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; yet our understanding remains limited on the characteristic of antibodies, especially for dynamic long-term tracking. Sequential serum samples were collected up to 416 days post onset of symptoms (POS) from 102 patients who were hospitalized with coronavirus disease 2019 (COVID-19). Immunoglobulin (Ig)G, IgM, and IgA levels targeting SARS-CoV-2 spike 1 receptor-binding domain (S1-RBD), spike 2 extracellular domain (S2-ECD), and nucleocapsid protein (N) were quantified as well as neutralizing activity. We were pleasantly surprised to find that the antibody remained detective and effective for more than a year POS. We also found the varied reactions of different antibodies as time passed: N-IgA rose most rapidly in the early stage of infection, while S2-IgG was present at a high level in the long time of observation. This study described the long traceable antibody response of the COVID-19 and offered hints about targets to screen for postinfectious immunity and for vaccination development of SARS-CoV-2. |Aged[MESH] |Antibodies, Neutralizing/*blood/immunology[MESH] |Antibodies, Viral/*blood/immunology[MESH] |COVID-19/diagnosis/*immunology[MESH] |Coronavirus Nucleocapsid Proteins/immunology[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Hospitalization[MESH] |Humans[MESH] |Immunoglobulin Isotypes/blood/immunology[MESH] |Kinetics[MESH] |Male[MESH] |Middle Aged[MESH] |Models, Theoretical[MESH] |Phosphoproteins/immunology[MESH] |Protein Domains/immunology[MESH] |SARS-CoV-2/*immunology/isolation & purification[MESH] |Seroconversion[MESH]Dynamic Characteristic Analysis of Antibodies in Patients With COVID-1(epmc).pdf DeepDyve Pubget Overpricing